REQUEST A DEMO
Total
USD $0.00
Search more companies

Beecham Pharmaceuticals (Pte) Ltd. (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Beecham Pharmaceuticals (Pte) Ltd. Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Beecham Pharmaceuticals (Pte) Ltd. is engaged in developing, manufacturing and distribution of semi-synthetic penicillin and other pharmaceutical products. The company offers pharmaceutical drugs, medicines and prescription drugs under "GSK" brands. Beecham Pharmaceuticals (Pte) Ltd. was incorporated in 1970 and is based in Singapore.

Headquarters
38 Quality Road, Jurong Ind Est, Singapore
Singapore; Singapore; Postal Code: 618809

Contact Details: Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.
Outstanding Shares:
Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.
Financial Auditors:
Purchase the Beecham Pharmaceuticals (Pte) Ltd. report to view the information.
Incorporation Date:
October 10, 1970
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Beecham Pharmaceuticals (Pte) Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency GBP. Absolute financial data is included in the purchased report.
Net sales revenue
17.62%
Total operating revenue
17.62%
Net Profit (Loss) for the Period
76.46%
Total assets
4.81%
Total equity
8.59%
Net Profit Margin
2.77%
Return on Equity (ROE)
3.04%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?